CD79A and poliomyelitis: Unlike the injectable inactivated polio vaccine (IPV), OPV was shown to induce secretory IgA antibody responses at the intestinal mucosae the site of virus replication helping effective control of poliovirus, making OPV a powerful strategy for global eradication of polio [27].